Leuprolide Acetate

Leuprolide acetate (Leuprorelin acetate) is a potent gonadotropin-releasing hormone receptor agonist used for the treatment of prostate cancer, endometriosis, uterine fibroids.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
Leuprolide Acetate(CAS 74381-53-6)

CAT No: 10-101-22

CAS No:74381-53-6

Synonyms/Alias:Leuprolide acetate;Leuprorelin acetate;Lupron;74381-53-6;Carcinil;Lucrin;Eligard;Enantone;Leuplin;Viadur;Lupron Depot;Abbott-43818;Prostap;TAP-144;Fensolvi;Leuprin;Lupaneta;Procrin;Trenantone;Leuplin depot;Lutrate depot;Procren Depot;Uno-Enantone;Depo-Lupron;LUPRON DEPOT-PED;Leuporelin acetate;Lupron PED;TAP-144-SR;Leuprolide Monoacetate;Enanton;Lutrate;Leuprolide acetate depot;LUPRON DEPOT-3;LUPRON DEPOT-4;Abbott 43818;CHEBI:63597;UNII-37JNS02E7V;37JNS02E7V;A-43818;Leuprolide (Acetate);DTXSID7049009;Leuprolide acetate [USAN:USP];DTXCID2028935;Leuprolide acetate [USAN];des-Gly10-[D-Leu6]-LH-RH ethylamide;Leuprolide acetate (USAN:USP);LEUPROLIDE ACETATE (USP-RS);LEUPROLIDE ACETATE [USP-RS];LEUPRORELIN ACETATE (MART.);LEUPRORELIN ACETATE [MART.];MFCD00072080;LEUPRORELIN ACETATE [JAN];LEUPROLIDE ACETATE (USP MONOGRAPH);LEUPROLIDE ACETATE [USP MONOGRAPH];Acetate, Leuprolide;LEUP;MFCD00167544;Ginecrin;Onectyl;Procren;Depo-Eligard;Enantone-Gyn;Fensolvi Kit;Lucrin Depot;Lupron Depot Ped;Leuprolide Acetate?;Lupron Depot-Ped Kit;ELIGARD KIT;Lupron Depot-3 Month;Lupron Depot-4 Month;LUTRATE DEPOT KIT;NCGC00183364-01;SCHEMBL3174;MLS000028695;CHEMBL1200775;LEUPROLIDE ACETATE [VANDF];LEUPROLIDE MONOACETATE [MI];Tox21_113507;BDBM50247891;LEUPRORELIN ACETATE [WHO-DD];s3718;AKOS015895632;AKOS030485977;CCG-270666;CS-1434;FL24877;LEUPROLIDE ACETATE [ORANGE BOOK];5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tryosyl-D-leucyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide monoacetate (salt);AC-28731;HY-13665;SMR000058945;CAS-74381-53-6;L0249;(Des-Gly10,D-Leu6,Pro-NHEt9)-LHRH acetate;Leuprolide Acetate (53714-56-0 free base);Pyr-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt.HOAc;Q27104908;PGLU-HIS-TRP-SER-TYR-D-LEU-LEU-ARG-PRO-NHC2H5 ACETATE SALT;5-OXO-L-PROLYL-L-HISTIDYL-L-TRYPTOPHYL-L-SERYL-L-TRYOSYL-D-LEUCYL-L-LEUCYL-L-ARGINYL-N-ETHYL-L-PROLINAMIDE ACETATE (SALT);5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tryosyl-D-leucyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide monoacetate;5-oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide--acetic acid (1/1);6-D-Leucine-9-(N-ethyl-L-prolinamide)-10-deglycinamideluteinizing hormone-releasing factor acetate;L-Prolinamide, 5-oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-N-ethyl-, acetate (1:1);

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C61H88N16O14
M.W/Mr.
1269.4
Sequence
One Letter Code:XHWSYLLRP
Three Letter Code:H-Pyr-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt.CH3CO2H
Activity
Agonist
Target
Gonadotropin-releasing hormone receptor

Leuprolide Acetate, also known as leuprorelin acetate, is a synthetic nonapeptide analog of gonadotropin-releasing hormone (GnRH) widely recognized for its potent ability to modulate hormonal signaling pathways. Characterized by its structural similarity to endogenous GnRH, Leuprolide Acetate acts as a powerful agonist, binding to pituitary GnRH receptors and eliciting a biphasic response that ultimately leads to downregulation of gonadotropin secretion. Its chemical stability, high receptor affinity, and predictable pharmacodynamic properties make it a valuable tool across a range of scientific and research settings, particularly in the fields of endocrinology, oncology, and reproductive biology. By providing consistent and reproducible hormonal suppression, this peptide compound facilitates the investigation of hormone-dependent physiological and pathological processes without the variability associated with native hormone fluctuations.

Endocrine Research Models: In endocrine research, Leuprolide Acetate is frequently employed to create controlled models of hormonal suppression, allowing scientists to study the intricate feedback mechanisms within the hypothalamic-pituitary-gonadal axis. By administering this GnRH analog, researchers can induce a reversible state of hypogonadism in animal models or cell cultures, which is instrumental in dissecting the roles of sex steroids in growth, metabolism, and behavior. Its precise action on gonadotropin release enables the differentiation between direct and indirect hormonal effects, providing clarity in complex experimental designs focused on endocrine regulation.

Cancer Biology Studies: The application of leuprorelin acetate extends to oncology research, where it is used to investigate the impact of gonadal hormone deprivation on the proliferation and progression of hormone-sensitive tumors. In preclinical studies, this compound serves as a reliable agent to suppress androgen or estrogen production, thereby facilitating the analysis of tumor biology in the absence of endogenous hormonal stimulation. Such models are essential for understanding the molecular pathways involved in hormone-dependent malignancies and for evaluating the efficacy of novel therapeutic interventions targeting these pathways.

Reproductive Physiology Investigations: Within the domain of reproductive biology, Leuprolide Acetate is a key tool for manipulating the estrous or menstrual cycle in laboratory animals. By precisely timing the administration of this peptide, researchers can synchronize ovulation, control the onset of reproductive cycles, or temporarily inhibit gonadal function. This capability is particularly valuable for studies exploring gametogenesis, fertility preservation, and the developmental consequences of altered hormonal environments. The reproducibility and reversibility of its effects offer significant advantages for experimental design and interpretation.

Assisted Reproductive Technology (ART) Protocols: In the context of ART research, leuprorelin acetate is utilized to prevent premature luteinizing hormone surges during controlled ovarian stimulation protocols. Its administration allows for the careful orchestration of follicular development, optimizing the retrieval of mature oocytes for in vitro fertilization studies. By modulating the hormonal milieu, this peptide enhances the consistency and success rates of ART procedures in experimental settings, supporting advancements in reproductive medicine and embryology research.

Neuroendocrine Mechanism Exploration: The influence of Leuprolide Acetate on the central regulation of reproductive hormones renders it an indispensable agent for neuroendocrine studies. Researchers leverage its ability to suppress gonadotropin release to probe the neural circuits and molecular mediators involved in GnRH signaling. These investigations deepen our understanding of brain-hormone interactions, sexual differentiation, and the neurobiological basis of reproductive behaviors. Furthermore, the compound's effects on neurotransmitter systems and neuroplasticity are of growing interest in studies examining the broader implications of hormonal modulation within the central nervous system.

Peptide analogs like Leuprolide Acetate continue to drive innovation across diverse scientific disciplines. Its unique mechanism of action, coupled with its versatility in experimental design, enables researchers to address fundamental questions in hormone biology, disease modeling, and therapeutic development. As new research methodologies emerge, the applications of this GnRH analog are likely to expand, offering further insights into the complex interplay between hormones, tissues, and disease processes.

Long-term Storage Conditions
H2O : ≥ 66.66 mg/mL (52.51 mM)
Shipping Condition
Room temperature in continental US; may vary elsewhere.
InChI
InChI=1S/C59H84N16O12.C2H4O2/c1-6-63-57(86)48-14-10-22-75(48)58(87)41(13-9-21-64-59(60)61)68-51(80)42(23-32(2)3)69-52(81)43(24-33(4)5)70-53(82)44(25-34-15-17-37(77)18-16-34)71-56(85)47(30-76)74-54(83)45(26-35-28-65-39-12-8-7-11-38(35)39)72-55(84)46(27-36-29-62-31-66-36)73-50(79)40-19-20-49(78)67-40;1-2(3)4/h7-8,11-12,15-18,28-29,31-33,40-48,65,76-77H,6,9-10,13-14,19-27,30H2,1-5H3,(H,62,66)(H,63,86)(H,67,78)(H,68,80)(H,69,81)(H,70,82)(H,71,85)(H,72,84)(H,73,79)(H,74,83)(H4,60,61,64);1H3,(H,3,4)/t40-,41-,42-,43+,44-,45-,46-,47-,48-;/m0./s1
InChI Key
RGLRXNKKBLIBQS-XNHQSDQCSA-N

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide CDMOPeptide Analysis ServicescGMP Peptide ServicePeptide Modification ServicesPeptide Nucleic Acids SynthesisEpitope Mapping ServicesCustom Conjugation ServicePeptide Synthesis Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers